These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8976364)

  • 21. Cytogenetic findings in invasive breast carcinomas with prognostically favourable histology: a less complex karyotypic pattern?
    Adeyinka A; Mertens F; Idvall I; Bondeson L; Ingvar C; Heim S; Mitelman F; Pandis N
    Int J Cancer; 1998 Aug; 79(4):361-4. PubMed ID: 9699527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
    Hunter SM; Anglesio MS; Sharma R; Gilks CB; Melnyk N; Chiew YE; deFazio A; ; Longacre TA; Huntsman DG; Gorringe KL; Campbell IG
    Clin Cancer Res; 2011 Dec; 17(23):7273-82. PubMed ID: 21976534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trisomy of chromosome 12 in a case of thecoma of the ovary.
    Mrózek K; Nedoszytko B; Babińska M; Mrózek E; Hrabowska M; Emerich J; Limon J
    Gynecol Oncol; 1990 Mar; 36(3):413-6. PubMed ID: 2156766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.
    Sadlecki P; Walentowicz P; Bodnar M; Marszalek A; Grabiec M; Walentowicz-Sadlecka M
    Tumour Biol; 2017 May; 39(5):1010428317706230. PubMed ID: 28488545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors.
    Streblow RC; Dafferner AJ; Nelson M; Fletcher M; West WW; Stevens RK; Gatalica Z; Novak D; Bridge JA
    Cancer Genet Cytogenet; 2007 Oct; 178(2):135-40. PubMed ID: 17954269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines.
    Murty VV; Dmitrovsky E; Bosl GJ; Chaganti RS
    Cancer Genet Cytogenet; 1990 Nov; 50(1):67-73. PubMed ID: 2253191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
    Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
    World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status.
    Singh N; Gilks CB; Huntsman DG; Smith JH; Coutts M; Ganesan R; McCluggage WG
    Histopathology; 2014 Apr; 64(5):626-32. PubMed ID: 24138090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
    Prat J; D'Angelo E; Espinosa I
    Hum Pathol; 2018 Oct; 80():11-27. PubMed ID: 29944973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.
    Choi YL; Kang SY; Shin YK; Choi JS; Kim SH; Lee SJ; Bae DS; Ahn G
    Virchows Arch; 2006 Mar; 448(3):331-6. PubMed ID: 16315018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
    Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH; Xie JL; Zhang YL; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent loss of chromosome 12 in human epithelial ovarian tumors: a chromosomal in situ hybridization study.
    Tanyi J; Tory K; Amo-Takyi BK; Füzesi L
    Int J Gynecol Pathol; 1998 Apr; 17(2):106-12. PubMed ID: 9553805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of extra chromosomes 12 by fluorescent in situ hybridization (FISH) in ovarian stromal tumors. Study of 12 cases and review of the literature].
    Gancberg D; Scourneau M; Verdebout JM; Larsimont D; Verhest A
    Ann Pathol; 2001 Oct; 21(5):393-8. PubMed ID: 11852357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trisomy 12 and translocation (7;9) in an ovarian immature teratoma.
    López Ginés C; Gil R; Pellin A; Martorell M; Vilar F; Llombart-Bosch A
    Int J Gynecol Pathol; 1989; 8(3):277-85. PubMed ID: 2767876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal p16 expression is significantly increased in malignant ovarian neoplasms.
    Yoon N; Yoon G; Park CK; Kim HS
    Oncotarget; 2016 Oct; 7(40):64665-64673. PubMed ID: 27572321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.